Eddie Sullivan is the President and CEO of SAB Biotherapeutics based in Sioux Falls. The company announced its first in-human trial of new immunotherapy in antibiotic resistance and saw success. SAB Biotherapeutics also announced the launch a Utah based company that uses goats to produce human therapeutics.
Innovation: Eddie Sullivan
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio
argusleader.com